References
- VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: a global and regional perspectiveOncologist201015Suppl 451321115576
- YangJDRobertsLREpidemiology and management of hepatocellular carcinomaInfect Dis Clin North Am20102489991920937457
- YuenMFHonCHuiCKSiuCWLaiCLRecombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinomaJ Clin Gastroenterol20023527227512192207
- ChuaCWChooSPTargeted therapy in hepatocellular carcinomaInt J Hepatol2011201119
- Le BuanecHGougeonMLMathianAIFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cellsProc Natl Acad Sci U S A2011108189951900022065791
- YiTElsonPMitsuhashiMPhosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsOncotarget201121155116422201704
- ShinoharaNAbeTSazawaAInterferon-alpha-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situJpn J Clin Oncol20124211311922131341
- SingalAKFreemanDHJrAnandBSMeta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinomaAliment Pharmacol Ther20103285185820659285
- BreitensteinSDimitroulisDPetrowskyHSystematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitisBr J Surg20099697598119672926
- WangBXRahbarRFishENInterferon: current status and future prospects in cancer therapyJ Interferon Cytokine Res20113154555221323567
- LesinskiGBRaigETGuenterbergKIFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisCancer Res2008688351836018922907
- SatthapornSAloysiusMMRobinsRAEx vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alphaBMC Immunol200893218588665
- XuanCStewardKKTimmermanJMMorrisonSLTargeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphomaBlood20101152864287120139095
- BukowskiRErnstoffMSGoreMEPegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II studyJ Clin Oncol2002203841384912228203
- WangYSYoungsterSGraceMBauschJBordensRWyssDFStructural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implicationsAdv Drug Deliv Rev20025454757012052714
- GalorAKarpCLChhabraSBarnesSAlfonsoECTopical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison studyBr J Ophthalmol20109455155419493859
- García-JimenoSEscribanoEQueraltJEstelrichJExternal magnetic field-induced selective biodistribution of magnetoliposomes in miceNanoscale Res Lett2012745222883385
- SinghRNalwaHSMedical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugsJ Biomed Nanotechnol2011748950321870454
- SolomonMD’SouzaGGRecent progress in the therapeutic applications of nanotechnologyCurr Opin Pediatr20112321522021412081
- JingHWangJYangPKeXXiaGChenBMagnetic Fe3O4 nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cellsInt J Nanomedicine20105999100421187919
- WangCZhangHChenBYinHWangWStudy of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticlesInt J Nanomedicine201161929193521931488
- KawaguchiEShimokawaKIshiiFPhysicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systemsColloids Surf B Biointerfaces20086213013517988839
- WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
- KimMJJangDHLeeYIJungHSLeeHJChoaYHPreparation, characterization, cytotoxicity and drug release behavior of liposome-enveloped paclitaxel/Fe3O4 nanoparticlesJ Nanosci Nanotechnol20111188989321446568
- CintiCTarantaMNaldiIGrimaldiSNewly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsPloS One2011617132
- EinatMResnitzkyDKimchiAClose link between reduction of c-myc expression by interferon, and G0/G1 arrestNature19853135976003881681
- Yamamoto-YamaguchiYOkabe-KadoJKasukabeTHonmaYInduction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cellAnticancer Res2003232537254712894538
- XuDEricksonSSzepsMInterferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cellsBlood2000964313431811110707
- AzzimontiBPaganoMMondiniMAltered patterns of the interferon inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation indexHistopathology20044556057215569046
- MatsuiWHuffCAValaMBarberJSmithBDJonesRJAnti-tumour activity of interferon alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiationBr J Haematol200312125125812694246
- YangEKorsmeyerSJMolecular thanatopsis: a discourse on the BCL2 family and cell deathBlood1996883864018695785
- MejíasRPérez-YagüeSGutiérrezLDimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapyBiomaterials2011322938295221277630
- JahnkeAHirschbergerJFischerCIntra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I studyJ Vet Med A Physiol Pathol Clin Med20075459960618045346
- DouHDestacheCJMoreheadJRDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood20061082827283516809617
- AmendolaVMeneghettiMGranozziGTop-down synthesis of multifunctional iron oxide nanoparticles for macrophage labeling and manipulationJ Mater Chem20112138033813
- CarvalhoAGonçalvesMCMartinsMBMeixedoDFeioGRelaxivities of magnetoliposomes: the effect of cholesterolMagn Reson Imaging20133161061223333578
- RudelTCaspase inhibitors in prevention of apoptosisHerz19992423624110412648
- HockenberyDNuñezGMillimanCSchreiberRDKorsmeyerSJBcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature19903483343362250705
- OltvaiZNMillimanCLKorsmeyerSJBcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell deathCell1993746096198358790
- ColletierJPChaizeBWinterhalterMFournierDProtein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayerBMC Biotechnol20022912003642